{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:42:36Z","timestamp":1772134956090,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005809","name":"Hyderabad Eye Research Foundation","doi-asserted-by":"publisher","award":["LEC-BHR-P-09-22-926"],"award-info":[{"award-number":["LEC-BHR-P-09-22-926"]}],"id":[{"id":"10.13039\/501100005809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005809","name":"Hyderabad Eye Research Foundation","doi-asserted-by":"publisher","award":["LEC-BHR-P-09-22-926"],"award-info":[{"award-number":["LEC-BHR-P-09-22-926"]}],"id":[{"id":"10.13039\/501100005809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005809","name":"Hyderabad Eye Research Foundation","doi-asserted-by":"publisher","award":["LEC-BHR-P-09-22-926"],"award-info":[{"award-number":["LEC-BHR-P-09-22-926"]}],"id":[{"id":"10.13039\/501100005809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005809","name":"Hyderabad Eye Research Foundation","doi-asserted-by":"publisher","award":["LEC-BHR-P-09-22-926"],"award-info":[{"award-number":["LEC-BHR-P-09-22-926"]}],"id":[{"id":"10.13039\/501100005809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1038\/s41433-023-02824-1","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T09:01:49Z","timestamp":1700038909000},"page":"1097-1103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of optical coherence tomography biomarkers to differentiate favourable and unfavourable responders to intravitreal anti-vascular endothelial growth factor treatment in retinopathy of prematurity"],"prefix":"10.1038","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4465-4765","authenticated-orcid":false,"given":"Akash","family":"Belenje","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakasi Ugandhar","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepika C.","family":"Parmeswarappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tapas Ranjan","family":"Padhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bala","family":"Subbarao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhadra","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"2824_CR1","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","volume":"128","author":"MF Chiang","year":"2021","unstructured":"Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Paul Chan RV, Berrocal A, et al. International classification of retinopathy of prematurity, third edition. Ophthalmology. 2021;128:e51\u201368. https:\/\/doi.org\/10.1016\/j.ophtha.2021.05.031.","journal-title":"Ophthalmology"},{"key":"2824_CR2","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.ophtha.2020.01.052","volume":"127","author":"KN Bellsmith","year":"2020","unstructured":"Bellsmith KN, Brown J, Kim SJ, Goldstein IH, Coyner A, Ostmo S, et al. Aggressive posterior retinopathy of prematurity: clinical and quantitative imaging features in a large North American Cohort. Ophthalmology. 2020;127:1105\u201312. https:\/\/doi.org\/10.1016\/j.ophtha.2020.01.052.","journal-title":"Ophthalmology"},{"key":"2824_CR3","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ajo.2010.10.007","volume":"151","author":"S Jalali","year":"2011","unstructured":"Jalali S, Kesarwani S, Hussain A. Outcomes of a protocol-based management for zone 1 retinopathy of prematurity: the Indian Twin Cities ROP Screening Program report number 2. Am J Ophthalmol. 2011;151:719\u201324.e2. https:\/\/doi.org\/10.1016\/j.ajo.2010.10.007.","journal-title":"Am J Ophthalmol"},{"key":"2824_CR4","first-page":"233","volume":"102","author":"WV Good","year":"2004","unstructured":"Good WV. Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc. 2004;102:233\u201348.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"2824_CR5","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1177\/11206721211073405","volume":"32","author":"A Beccasio","year":"2022","unstructured":"Beccasio A, Mignini C, Caricato A, Iaccheri B, Di Cara G, Verrotti A, et al. New trends in intravitreal anti-VEGF therapy for ROP. Eur J Ophthalmol. 2022;32:1340\u201351. https:\/\/doi.org\/10.1177\/11206721211073405.","journal-title":"Eur J Ophthalmol"},{"key":"2824_CR6","doi-asserted-by":"publisher","first-page":"806","DOI":"10.18240\/ijo.2020.05.17","volume":"13","author":"SD Wang","year":"2020","unstructured":"Wang SD, Zhang GM, Shenzhen Screening for Retinopathy of Prematurity Cooperative Group. Laser therapy versus intravitreal injection of anti-VEGF agents in monotherapy of ROP: a meta-analysis. Int J Ophthalmol. 2020;13:806\u201315. https:\/\/doi.org\/10.18240\/ijo.2020.05.17.","journal-title":"Int J Ophthalmol"},{"key":"2824_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"HA Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ, BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N. Engl J Med. 2011;364:603\u201315. https:\/\/doi.org\/10.1056\/NEJMoa1007374.","journal-title":"N. Engl J Med"},{"key":"2824_CR8","first-page":"29","volume":"68","author":"R Autrata","year":"2012","unstructured":"Autrata R, Senkov\u00e1 K, Holousov\u00e1 M, Krejc\u00edrov\u00e1 I, Dolezel Z, Borek I. Pr\u00ednos intravitre\u00e1ln\u00ed aplikace anti-VEGF prepar\u00e1t\u016f v l\u00e9cbe prahov\u00e9ho stadia ROP 3+ v z\u00f3ne I\u2013II: v\u00fdsledky ctyrlet\u00e9 studie [Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II-four years results]. Cesk Slov Oftalmol. 2012;68:29\u201336.","journal-title":"Cesk Slov Oftalmol"},{"key":"2824_CR9","doi-asserted-by":"publisher","first-page":"CD009734","DOI":"10.1002\/14651858.CD009734.pub3","volume":"1","author":"MJ Sankar","year":"2018","unstructured":"Sankar MJ, Sankar J, Chandra P. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity. Cochrane Database Syst Rev. 2018;1:CD009734. https:\/\/doi.org\/10.1002\/14651858.CD009734.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"2824_CR10","doi-asserted-by":"publisher","unstructured":"Belenje, A, Reddy, RU, Optom, B, Agarwal K, Parmeswarappa DC, Jalali S. Non-contact widefield neonatal retinal imaging for retinopathy of prematurity using the Clarus 700 high resolution true colour reflectance imaging. Eye. 2022. https:\/\/doi.org\/10.1038\/s41433-022-02273-2.","DOI":"10.1038\/s41433-022-02273-2"},{"key":"2824_CR11","doi-asserted-by":"publisher","first-page":"797684","DOI":"10.3389\/fped.2021.797684","volume":"9","author":"TP Nguyen","year":"2022","unstructured":"Nguyen TP, Ni S, Khan S, Wei X, Ostmo S, Chiang MF, et al. Advantages of widefield optical coherence tomography in the diagnosis of retinopathy of prematurity. Front Pediatr. 2022;9:797684. https:\/\/doi.org\/10.3389\/fped.2021.797684.","journal-title":"Front Pediatr"},{"key":"2824_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.clp.2013.02.007","volume":"40","author":"RS Maldonado","year":"2013","unstructured":"Maldonado RS, Toth CA. Optical coherence tomography in retinopathy of prematurity: looking beyond the vessels. Clin Perinatol. 2013;40:271\u201396. https:\/\/doi.org\/10.1016\/j.clp.2013.02.007.","journal-title":"Clin Perinatol"},{"key":"2824_CR13","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/s41433-021-01694-9","volume":"36","author":"A Hans","year":"2022","unstructured":"Hans A, Narang S, Sindhu M, Jain S, Chawla D. Fundus fluorescein angiography in retinopathy of prematurity. Eye (Lond). 2022;36:1604\u20139. https:\/\/doi.org\/10.1038\/s41433-021-01694-9.","journal-title":"Eye (Lond)"},{"key":"2824_CR14","doi-asserted-by":"publisher","first-page":"840030","DOI":"10.3389\/fmed.2022.840030","volume":"9","author":"W Tan","year":"2022","unstructured":"Tan W, Li B, Wang Z, Zou J, Jia Y, Yoshida S, et al. Novel potential biomarkers for retinopathy of prematurity. Front Med (Lausanne). 2022;9:840030. https:\/\/doi.org\/10.3389\/fmed.2022.840030.","journal-title":"Front Med (Lausanne)"},{"key":"2824_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/iovs.62.3.2","volume":"62","author":"A Vinekar","year":"2021","unstructured":"Vinekar A, Nair AP, Sinha S, Vaidya T, Chakrabarty K, Shetty R, et al. Tear fluid angiogenic factors: potential noninvasive biomarkers for retinopathy of prematurity screening in preterm infants. Invest Ophthalmol Vis Sci. 2021;62:2. https:\/\/doi.org\/10.1167\/iovs.62.3.2.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2824_CR16","doi-asserted-by":"publisher","unstructured":"Sehgal P, Narang S, Chawla D, Gupta S, Jain S, Sharma U, et al. Systemic biomarkers of retinopathy of prematurity in preterm babies. Int Ophthalmol. 2022. https:\/\/doi.org\/10.1007\/s10792-022-02576-z.","DOI":"10.1007\/s10792-022-02576-z"},{"key":"2824_CR17","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.4103\/ijo.IJO_1484_21","volume":"70","author":"TR Padhi","year":"2022","unstructured":"Padhi TR, Bhusal U, Padhy SK, Patel A, Kelgaonker A, Khalsa A, et al. The retinal vascular growth rate in babies with retinopathy of prematurity could indicate treatment need. Indian J Ophthalmol. 2022;70:1270\u20137.","journal-title":"Indian J Ophthalmol"},{"key":"2824_CR18","first-page":"S4","volume":"31","author":"K Agarwal","year":"2018","unstructured":"Agarwal K, Jalali S. Classification of retinopathy of prematurity: from then till now. Community Eye Health. 2018;31:S4\u20137.","journal-title":"Community Eye Health"},{"key":"2824_CR19","unstructured":"https:\/\/www.optos.com\/products\/silverstone\/."},{"key":"2824_CR20","doi-asserted-by":"publisher","first-page":"F327","DOI":"10.1136\/archdischild-2012-302365","volume":"98","author":"S Jalali","year":"2013","unstructured":"Jalali S, Balakrishnan D, Zeynalova Z, Padhi TR, Rani PK. Serious adverse events and visual outcomes of rescue therapy using adjunct bevacizumab to laser and surgery for retinopathy of prematurity. The Indian Twin Cities Retinopathy of Prematurity Screening database Report number 5. Arch Dis Child Fetal Neonatal Ed. 2013;98:F327\u201333. https:\/\/doi.org\/10.1136\/archdischild-2012-302365.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2824_CR21","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1097\/IAE.0000000000003196","volume":"41","author":"C Iwahashi","year":"2021","unstructured":"Iwahashi C, Utamura S, Kuniyoshi K, Sugioka K, Konishi Y, Wada N, et al. Factors associated with reactivation after intravitreal bevacizumab or ranibizumab therapy in infants with retinopathy of prematurity. Retina. 2021;41:2261\u20138.","journal-title":"Retina"},{"key":"2824_CR22","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/archophthalmol.2012.592","volume":"130","author":"J Hu","year":"2012","unstructured":"Hu J, Blair MP, Shapiro MJ, Lichtenstein SJ, Galasso JM, Kapur R. Reactivation of retinopathy of prematurity after bevacizumab injection. Arch Ophthalmol. 2012;130:1000\u20136.","journal-title":"Arch Ophthalmol"},{"key":"2824_CR23","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.ophtha.2016.04.028","volume":"123","author":"HA Mintz-Hittner","year":"2016","unstructured":"Mintz-Hittner HA, Geloneck MM, Chuang AZ. Clinical management of recurrent retinopathy of prematurity after intravitreal bevacizumab monotherapy. Ophthalmology. 2016;123:1845\u201355.","journal-title":"Ophthalmology"},{"key":"2824_CR24","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.3928\/23258160-20180907-16","volume":"49","author":"EH Wood","year":"2018","unstructured":"Wood EH, Rao P, Moysidis SN, Dedania VS, Elman MJ, Drenser KA, et al. Fellow Eye anti-VEGF \u2018Crunch\u2019 effect in retinopathy of prematurity. Ophthalmic Surg Lasers Imaging Retin. 2018;49:e102\u20134. https:\/\/doi.org\/10.3928\/23258160-20180907-16.","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"key":"2824_CR25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/archopthalmol.2011.1846","volume":"130","author":"RS Maldonado","year":"2012","unstructured":"Maldonado RS, O\u2019Connell R, Ascher SB, Sarin N, Freedman SF, Wallace DK, et al. Spectral-domain optical coherence tomographic assessment of severity of cystoid macular edema in retinopathy of prematurity. Arch Ophthalmol. 2012;130:569\u201378. https:\/\/doi.org\/10.1001\/archopthalmol.2011.1846.","journal-title":"Arch Ophthalmol"},{"key":"2824_CR26","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.oret.2018.02.001","volume":"2","author":"X Chen","year":"2018","unstructured":"Chen X, Mangalesh S, Dandridge A, Tran-Viet D, Wallace DK, Freedman SF, et al. Spectral-Domain OCT findings of retinal vascular-avascular junction in infants with retinopathy of prematurity. Ophthalmol Retin. 2018;2:963\u201371. https:\/\/doi.org\/10.1016\/j.oret.2018.02.001.","journal-title":"Ophthalmol Retin"},{"key":"2824_CR27","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.2147\/OPTH.S260000","volume":"14","author":"O Furashova","year":"2020","unstructured":"Furashova O, Matth\u00e8 E. Hyperreflectivity of inner retinal layers as a quantitative parameter of ischemic damage in acute retinal vein occlusion (RVO): an optical coherence tomography study. Clin Ophthalmol. 2020;14:2453\u201362. https:\/\/doi.org\/10.2147\/OPTH.S260000.","journal-title":"Clin Ophthalmol"},{"key":"2824_CR28","doi-asserted-by":"publisher","first-page":"852022","DOI":"10.3389\/fmed.2022.852022","volume":"9","author":"YT Huang","year":"2022","unstructured":"Huang YT, Chang YC, Meng PP, Lin CJ, Lai CT, Hsia NY, et al. Optical coherence tomography biomarkers in predicting treatment outcomes of diabetic macular edema after dexamethasone implants. Front Med (Lausanne). 2022;9:852022. https:\/\/doi.org\/10.3389\/fmed.2022.852022.","journal-title":"Front Med (Lausanne)"},{"key":"2824_CR29","doi-asserted-by":"publisher","first-page":"854288","DOI":"10.3389\/fmed.2022.854288","volume":"9","author":"DA Wenzel","year":"2022","unstructured":"Wenzel DA, Poli S, Casagrande M, Druchkiv V, Spitzer MS, Bartz-Schmidt KU, et al. Inner retinal layer hyperreflectivity is an early biomarker for acute central retinal artery occlusion. Front Med (Lausanne). 2022;9:854288. https:\/\/doi.org\/10.3389\/fmed.2022.854288.","journal-title":"Front Med (Lausanne)"},{"key":"2824_CR30","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1001\/jamaophthalmol.2013.5052","volume":"131","author":"W Wu","year":"2013","unstructured":"Wu W, Shih C, Wang N, Lien R, Chen YP, Chao AN, et al. Choroidal thickness in patients with a History of retinopathy of prematurity. JAMA Ophthalmol. 2013;131:1451\u20138. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.5052.","journal-title":"JAMA Ophthalmol"},{"key":"2824_CR31","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1097\/IAE.0000000000000866","volume":"36","author":"MK Erol","year":"2016","unstructured":"Erol MK, Coban DT, Ozdemir O, Dogan B, Tunay ZO, Bulut M. Choroidal thickness in infants with retinopathy of prematurity. Retina. 2016;36:1191\u20138. https:\/\/doi.org\/10.1097\/IAE.0000000000000866.","journal-title":"Retina"},{"key":"2824_CR32","doi-asserted-by":"publisher","first-page":"7054","DOI":"10.3390\/ijerph18137054","volume":"18","author":"E Pheng","year":"2021","unstructured":"Pheng E, Lim ZD, Tai Li Min E, Rostenberghe HV, Shatriah I. Haemoglobin levels in early life among infants with and without retinopathy of prematurity. Int J Environ Res Public Health. 2021;18:7054. https:\/\/doi.org\/10.3390\/ijerph18137054.","journal-title":"Int J Environ Res Public Health"},{"key":"2824_CR33","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/eye.2017.76","volume":"31","author":"C Stutchfield","year":"2017","unstructured":"Stutchfield C, Jain A, Odd D, Williams C, Markham R. Foetal haemoglobin, blood transfusion, and retinopathy of prematurity in very preterm infants: a pilot prospective cohort study. Eye. 2017;31:1451\u20135. https:\/\/doi.org\/10.1038\/eye.2017.76.","journal-title":"Eye"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02824-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02824-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02824-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T10:04:08Z","timestamp":1712829848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02824-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["2824"],"URL":"https:\/\/doi.org\/10.1038\/s41433-023-02824-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3210423\/v1","asserted-by":"object"}]},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"assertion":[{"value":"27 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"IRB approved with ethics number LEC-BHR-P-09-22-926.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Has been obtained from the person shown in Fig.\n                      \n                      to use their image in published media.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}